Histopathological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) as Predictive Biomarker for Hormone Receptors Status, Proliferative Activity and Clinical Outcome in Her-2 Positive Breast Cancer
Authors:
- Giuseppe AngelicoGiuseppe Angelico
- Giuseppe BroggiGiuseppe Broggi
- Rosario CaltabianoRosario Caltabiano
- Angela SantoroASAngela Santoro
- Saveria SpadolaSSSaveria Spadola
- Nicoletta D’alessandrisNDNicoletta D’alessandris
- Giulia ScaglioneGSGiulia Scaglione
- Michele ValenteMVMichele Valente
- Damiano ArciuoloDADamiano Arciuolo
- Alejandro Martin SanchezAlejandro Martin Sanchez
- Gianluca FranceschiniGianluca Franceschini
- Riccardo MasettiRiccardo Masetti
Open Access
- 23 July 2021
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 11 (15) , 6788
Abstract
Background: In the present study, we evaluated the prognostic value of TILs as well their relation with clinicopathological factors in patients affected by HER-2 positive breast cancer. Methods: We evaluated 47 patients with a histologically confirmed diagnosis of invasive breast carcinoma showing an immunohistochemically confirmed (score 3+) amplification of the c-erbB-2 gene for the presence of TILs and categorized in three predefined groups of low (0–10% immune cells in stromal tissue within the tumor), intermediate (11–40%), and high TILs (>40%). Results: Low, intermediate and high TILs were found in 17/47 (36%), 23/47 (49%) and 7/47(15%) cases, respectively. It was found that 6/47 cases treated with adjuvant chemotherapy plus trastuzumab underwent progression of the disease; none of these cases exhibited high TILs. It was found that 12/47 patients with a prognostically unfavorable stage of III and IV showed low and intermediate levels of TILs, while high TILs were never observed. A significant association between intermediate/high-levels of TILs, elevated KI 67 index and hormone receptors nuclear staining was observed. High concordance in TILs distribution was observed between preoperative breast biopsies and surgical samples. Conclusions: We observed a positive correlation between the TILs and the response to both adjuvant and neoadjuvant treatments in HER-2 positive BC. High TILs were also related to increased KI-67 index and to the expression of hormone receptors.Keywords
This publication has 29 references indexed in Scilit:
- Immune checkpoint inhibitors in adjuvant setting after radical resection of melanoma: a meta-analysis of the pivotal trialsHuman Vaccines & Immunotherapeutics, 2021
- The efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy in patients with previously treated advanced non-small-cell lung cancerMedicine, 2021
- Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-AnalysisFrontiers in Oncology, 2021
- Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasionEuropean Journal of Surgical Oncology, 2021
- Molecular Investigation on a Triple Negative Breast Cancer Xenograft Model Exposed to Proton BeamsInternational Journal of Molecular Sciences, 2020
- MacroH2A1 Immunoexpression in Breast CancerFrontiers in Oncology, 2020
- Practical approach to diagnosis of bland-looking spindle cell lesions of the breastPathologica, 2019
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapyThe Lancet Oncology, 2018
- The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancerOncotarget, 2017
- Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinomaGynecologic Oncology, 2008